These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28796639)

  • 1. Development and validation of a multivariable prediction rule for detecting a severe acquired ADAMTS13 activity deficiency in patients with thrombotic microangiopathies.
    Nieto JM; De La Fuente-Gonzalo F; González FA; Villegas A; Martínez R; Fuentes ME; Ropero P
    Clin Chem Lab Med; 2018 Jan; 56(2):294-302. PubMed ID: 28796639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study.
    Bendapudi PK; Hurwitz S; Fry A; Marques MB; Waldo SW; Li A; Sun L; Upadhyay V; Hamdan A; Brunner AM; Gansner JM; Viswanathan S; Kaufman RM; Uhl L; Stowell CP; Dzik WH; Makar RS
    Lancet Haematol; 2017 Apr; 4(4):e157-e164. PubMed ID: 28259520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
    Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
    Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.
    Joly BS; Stepanian A; Leblanc T; Hajage D; Chambost H; Harambat J; Fouyssac F; Guigonis V; Leverger G; Ulinski T; Kwon T; Loirat C; Coppo P; Veyradier A;
    Lancet Haematol; 2016 Nov; 3(11):e537-e546. PubMed ID: 27720178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry.
    Hassan S; Westwood JP; Ellis D; Laing C; Mc Guckin S; Benjamin S; Scully M
    Br J Haematol; 2015 Dec; 171(5):830-5. PubMed ID: 26359646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lombardy diagnostic and therapeutic network of thrombotic microangiopathy.
    Mancini I; Agosti P; Boscarino M; Ferrari B; Artoni A; Palla R; Spreafico M; Crovetti G; Volpato E; Rossini S; Novelli C; Gattillo S; Barcella L; Salmoiraghi M; Falanga A; Peyvandi F;
    Orphanet J Rare Dis; 2022 Jun; 17(1):246. PubMed ID: 35739601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAMTS13 Testing Methodologies and Thrombotic Thrombocytopenic Purpura (TTP): Conflicting Results Can Pose a Clinical Dilemma.
    Pandey S; Cottler-Fox M
    Ann Clin Lab Sci; 2018 May; 48(3):373-376. PubMed ID: 29970443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008.
    Fujimura Y; Matsumoto M
    Intern Med; 2010; 49(1):7-15. PubMed ID: 20045995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
    Shenkman B; Einav Y
    Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative.
    Bendapudi PK; Li A; Hamdan A; Uhl L; Kaufman R; Stowell C; Dzik W; Makar RS
    Br J Haematol; 2015 Dec; 171(5):836-44. PubMed ID: 26314936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center.
    Martin SD; McGinnis E; Smith TW
    Am J Clin Pathol; 2021 Nov; 156(6):1103-1112. PubMed ID: 34160013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment.
    Li A; Khalighi PR; Wu Q; Garcia DA
    J Thromb Haemost; 2018 Jan; 16(1):164-169. PubMed ID: 29064619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.
    Mariotte E; Azoulay E; Galicier L; Rondeau E; Zouiti F; Boisseau P; Poullin P; de Maistre E; Provôt F; Delmas Y; Perez P; Benhamou Y; Stepanian A; Coppo P; Veyradier A;
    Lancet Haematol; 2016 May; 3(5):e237-45. PubMed ID: 27132698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the PLASMIC score for predicting ADAMTS13 activity <10% in patients with suspected thrombotic thrombocytopenic purpura in Alberta, Canada.
    Wynick C; Britto J; Sawler D; Parker A; Karkhaneh M; Goodyear MD; Sun HL
    Thromb Res; 2020 Dec; 196():335-339. PubMed ID: 32977133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of a clinical prediction score for thrombotic thrombocytopenic purpura in an independent cohort.
    Bentley MJ; Wilson AR; Rodgers GM
    Vox Sang; 2013 Nov; 105(4):313-8. PubMed ID: 23662653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a New, Rapid, Fully Automated Assay for the Measurement of ADAMTS13 Activity.
    Valsecchi C; Mirabet M; Mancini I; Biganzoli M; Schiavone L; Faraudo S; Mane-Padros D; Giles D; Serra-Domenech J; Blanch S; Trisolini SM; Facchini L; Rinaldi E; Peyvandi F
    Thromb Haemost; 2019 Nov; 119(11):1767-1772. PubMed ID: 31587247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical presentations of thrombotic thrombocytopenic purpura: a diagnostic role for ADAMTS13.
    Kalish Y; Rottenstreich A; Rund D; Hochberg-Klein S
    J Thromb Thrombolysis; 2016 Aug; 42(2):155-60. PubMed ID: 26867546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of PLASMIC score and follow-up data in a cohort of patients with suspected microangiopathies from Southern Italy.
    Tiscia GL; Ostuni A; Cascavilla N; Cappucci F; Scalzulli P; Battista C; Abrescia A; Aucella F; Buquicchio C; Brigante M; D'Andrea G; Di Paolo B; Giordano G; Infante B; Piano S; Ranieri P; Tullo L; Grandone E
    J Thromb Thrombolysis; 2018 Aug; 46(2):174-179. PubMed ID: 29737462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced sensitivity of PLASMIC and French scores for the diagnosis of thrombotic thrombocytopenic purpura in older individuals.
    Liu A; Dhaliwal N; Upreti H; Kasmani J; Dane K; Moliterno A; Braunstein E; Brodsky R; Chaturvedi S
    Transfusion; 2021 Jan; 61(1):266-273. PubMed ID: 33179792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.